Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 40 of the 83 sources its claims cite were checked for support.
Abstract
Randomized parallel intervention comparing soybean oil, palm olein, and cocoa butter in healthy adults; secondary outcomes included serum lipids.
Overview
CoChat Summary
TL;DR
In healthy adults, 16-week eucaloric diets enriched with palm olein, cocoa butter, or soybean oil did not differentially affect liver fat concentration or abdominal adipose tissue. Soybean oil lowered total and LDL cholesterol versus palm olein, and soybean oil and cocoa butter reduced body fat mass versus palm olein.
Key findings
- Liver fat concentration, hepatic saturation index, visceral adipose tissue, abdominal subcutaneous adipose tissue, and VAT:aSCAT did not differ between diets after 16 weeks.
- Body fat mass decreased with SBO and COB compared with POo; estimated marginal mean (95% CI) differences in change at 16 weeks were −1.35 (−2.39, −0.30) kg for SBO vs POo and −1.18 (−2.25, −0.11) kg for COB vs POo.
- SBO lowered serum total cholesterol, LDL cholesterol, and TC:HDL cholesterol relative to POo; estimated marginal mean (95% CI) differences in change from baseline to 16 weeks were −0.57 (−0.94, −0.20) mmol/L, −0.37 (−0.68, −0.07) mmol/L, and −0.42 (−0.73, −0.11) mmol/L, respectively.
- No diet differences were observed for HDL cholesterol, TAG, apoA1, apoB, apoB:apoA1, or fecal total fat; fecal FFA pentadecanoic acid (15:0) was lower with COB than with SBO and POo.
Methods
- A 16-week single-blinded, randomized, 3-arm parallel feeding trial preceded by a 2-week run-in; 83 healthy participants aged 20–45 years with BMI 18.5–27.5 kg/m² commenced and 64 completed.
- Participants consumed identical eucaloric background diets differing in test fats contributing 20% total energy intake, providing 33% energy as total fat; PUFA/SFA/MUFA ratios were POo 4.2/13.5/15%E, SBO 14.4/8.8/9.4%E, and COB 2.3/19.5/11%E.
- Liver fat and abdominal adiposity were measured at weeks 0 and 16 by ¹H-MRS/MRI; other outcomes were measured at 0, 4, 8, 12, and 16 weeks. ANCOVA was used for week 0–16 outcomes, and mixed-effects longitudinal models for repeated measures, controlling for baseline values, baseline BMI, and gender.
Limitations
- The paper states restricted generalizability to healthy adults aged 18–45 years, bias from completers rather than intention-to-treat analysis, that ¹H-MRS cannot differentiate contributions from different fatty acid types, and that P values were not adjusted for multiple secondary outcomes, so type 1 errors may have occurred.
- The paper also notes possible insufficient statistical power/type 2 error for fecal FFA outcomes due to large interindividual variability and modest increases.
- Evident from the text: attrition was 23%, with greater withdrawal due to dislike of study foods in the COB group (n = 6) than in SBO and POo groups (n = 2 each), and several baseline anthropometric/body composition variables appeared higher and more variable in the POo group, although analyses controlled for baseline BMI and respective baseline values.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
25 Valid · 3 Not valid · 10 Not checked · 98 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In contrast to the current study, results from previous clinical trials showed lower liver fat concentrations in response to highunsaturated fatty acid than in response to high-SFA diets (10-12).”
What the sources say
- Not checked — no full text of the sourcecites [10] Bjermo, 2012, Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial, Am J Clin Nutr. source
- Supportedcites [11] Luukkonen, 2018, Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars, Diabetes Care. source
The Conclusions report that, in a clinical overfeeding trial, saturated fat caused a greater increase in liver fat than unsaturated fat. Both diets increased liver fat, but the increase was smaller with unsaturated fat, supporting the cited comparison. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [12] Rosqvist, 2014, Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans, Diabetes. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other studies investigating the effects of SFAs on liver fat used mostly butter to increase the diet's SFA content (10, 11, 13).”
What the sources say
- Not checked — no full text of the sourcecites [10] Bjermo, 2012, Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial, Am J Clin Nutr. source
- Partly supportedcites [11] Luukkonen, 2018, Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars, Diabetes Care. sourceExperimental — accuracy not yet measured
The Study Design section reports that the saturated-fat diet included butter and that the study measured liver fat. But butter was not the predominant food used to increase saturated fat: the diet also supplied 30 g coconut oil and 100 g blue cheese per day alongside 40 g butter. (LLM, conf=0.90)
- Partly supportedcites [13] Summers, 2002, Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity, Diabetologia. sourceExperimental — accuracy not yet measured
The Subjects section describes an SFA-versus-PUFA dietary study in which participants usually substituted dairy products for PUFA-based spreads and cooking oils. It does not say that butter was the main source of SFA. The same section says the MRI assessment measured abdominal subcutaneous and visceral fat, not liver fat. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“On the contrary, evidence from nutrition intervention studies in animal models has been inconsistent.”
What the sources say
- Not checked — no full text of the sourcecites [14] de Wit, 2012, Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine, Am J Physiol Gastrointest Liver Physiol. source
- Could not verifycites [15] Catta-Preta, 2012, Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets, Nutrition. sourceExperimental — accuracy not yet measured
The Discussion says few animal studies compare different high-fat diet components and that the role of monounsaturated fats is unclear. It does not say that findings across animal nutrition intervention studies have been inconsistent; the animal comparisons it describes point in the same direction. Searched our copy for inconsistent or conflicting intervention results. (LLM, conf=0.73)
- Not checked — no full text of the sourcecites [16] Matsuo, 2002, Body fat accumulation is greater in rats fed a beef tallow diet than in rats fed a safflower or soybean oil diet, Asia Pac J Clin Nutr. source
- Not checked — no full text of the sourcecites [17] Shimomura, 1990, Less body fat accumulation in rats fed a safflower oil diet than in rats fed a beef tallow diet, J Nutr. source
- Not checked — no full text of the sourcecites [18] Ikemoto, 1996, High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils, Metabolism. source
- Not checked — no full text of the sourcecites [19] Stachon, 2006, Effects of high-fat diets on body composition, hypothalamus NPY, and plasma leptin and corticosterone levels in rats, Endocrine. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It was calculated that a sample size of 24 participants/group would provide 80% power at α = 0.05 to detect a minimum difference of 1.5% in liver fat concentration between treatments.”
What the sources say
- Could not verifycites [3] Bakker, 2014, A 5-day high-fat, high-calorie diet impairs insulin sensitivity in healthy, young South Asian men but not in Caucasian men, Diabetes. sourceExperimental — accuracy not yet measured
The Statistical Analysis section (p. 4) sets significance at P < 0.05, and Baseline Comparisons (p. 7) mentions a power calculation, but neither gives its parameters. The Subjects section (p. 3) reports 12 participants per group. Searches for 24 per group, 80% power, and a 1.5% liver-fat difference found no passage establishing the claimed calculation. (LLM, conf=0.73)
- Partly supportedcites [35] Kechagias, 2011, Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study, Ann Med. sourceExperimental — accuracy not yet measured
The Statistics section (page unavailable) uses a 0.05 significance level and reports a power calculation for hepatic triglyceride content, but it gives 86% power to detect an increase in the red-wine group versus controls, not the claimed 80% for a 1.5% difference. The Methods section (page unavailable) reports 44 participants randomized in total. Our copy does not state a calculation for 24 participants per group or a 1.5% minimum difference. (LLM, conf=0.85)
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, previous trials, albeit employing different dietary interventions compared with this study, demonstrated changes in liver fat concentration in healthy, non-NAFLD populations within timeframes of ≤ 12 wk (6, 38).”
What the sources say
- Not checked — no full text of the sourcecites [6] Sobrecases, 2010, Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men, Diabetes Metab. source
- Supportedcites [38] Martens, 2014, The potential of a high protein-low carbohydrate diet to preserve intrahepatic triglyceride content in healthy humans, PLoS One. source
The Discussion (page not supplied) describes a 12-week dietary trial in healthy, non-obese subjects and says intrahepatic triglyceride content changed in different directions between the diet groups. The Results table (page not supplied) shows the changes; the between-group difference nearly, but did not, reach statistical significance (P = 0.055). The citing sentence claims changes, not a statistically significant effect. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
60 more claims · 3 with their cited sources checked
Create a free account to see all 136 claims and every source verdict.
- Probably not a substantial claim. 58
- It may state two separate claims as one. 29
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Fecal total fat and FFAs · p. 8
“The estimated marginal mean (95% CI) difference in change at 16 wk for fecal FFA stearic acid between COB and SBO was 18.3% (7.4%, 29.2%) and between COB and POo was 22.7% (11.3%, 34.0%);”
§ Fecal total fat and FFAs · p. 8
“Total fecal fat and other fecal FFA concentrations did not differ significantly between groups ( Table 6 ).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis · p. 6
“Statistical analyses were performed on changes from baseline calculated by subtracting 4-, 8- 12-, and 16-wk data from baseline data.”
§ Discussion · p. 8
“although total body FM was reduced with SBO and COB relative to POo ( -3.6% and -2.83% with SBO and COB, respectively, compared with 3.6% with POo).”
Citations
Cites
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Predicting basal metabolic rate, new standards and review of previous work.
Wn, S. (1985) · PubMed · Cited by 2,958
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1825 · Cited by 1,751
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Body Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
A Better Index of Body Adiposity
Bergman, R. N., Stefanovski, D., Buchanan, T. A., Sumner, A. E., Reynolds, J. C., Sebring, N. G., Xiang, A. H., & Watanabe, R. M. (2011) · Obesity · doi:10.1038/oby.2011.38 · Cited by 999
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels
Bonanome, A., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181905 · Cited by 915
Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Self-citation
Cited by
Cao, X., Xia, J., Zhou, Y., Wang, Y., Xia, H., Wang, S., Liao, W., & Sun, G. (2022) · Foods · doi:10.3390/foods11131982 · Cited by 65
“8 28/27 Avocado 20/0 b Parallel Griel [27] 2008 America 50.”
BackgroundResultInfluentialMäkelä, T. N., Tuomainen, T., Hantunen, S., & Virtanen, J. K. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac150 · Cited by 54
“In experimental studies, overfeeding SFA caused lipid accumulation into the liver compared with overfeeding with PUFAs (9–11), although not all studies agree with these results (12).”
ResultSellem, L., Flourakis, M., Jackson, K. G., Joris, P. J., Lumley, J. A., Lohner, S., Mensink, R. P., Soedamah‐Muthu, S. S., & Lovegrove, J. A. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab143 · Cited by 43
“Other dietary fat replacements and their impact on apoB concentrations were investigated in 12 RCTs and are described in Table 3 (26, 34, 38, 40, 44, 53, 59, 60, 63, 65, 66, 68).”
BackgroundMethodInfluentialCole, R. M., Angelotti, A., Sparagna, G. C., Ni, A., & Belury, M. A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101132 · Cited by 21
Guo, P., Xue, M., Teng, X., Wang, Y., Ren, R., Han, J., Zhang, H., Tian, Y., & Liang, H. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109061 · Cited by 29
Metadata
- Authors
- Stonehouse, W., Sergi, D., Benassi-Evans, B., James-Martin, G., Johnson, N., Thompson, C. H., & Abeywardena, M.
- Affiliations
- Commonwealth Scientific and Industrial Research Organisation (AU)
- The University of Sydney (AU)
- The University of Adelaide (AU)
- Corresponding author
- Stonehouse, Welma
- ORCID
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 113
- Issue
- 2
- Pages
- 324-337
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W3113501998
- Cited by
- 16
- References
- 54
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 729 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- Funders
- Malaysian Palm Oil Board
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver fat, dietary fat quality, palm olein, cocoa butter, soybean oil, eucaloric diet, visceral adipose tissue, subcutaneous abdominal fat, abdominal fat, serum cholesterol, LDL cholesterol, HDL cholesterol, apolipoproteins, cardiometabolic health, healthy young adults, triacylglycerol composition
- MeSH terms
- Palm Oil, Adipose Tissue, Adult, Energy Intake, Dietary Fats, Fatty Acids, Nonesterified, Feces, Female, Humans, Liver, Male, Soybean Oil
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial. https://app.cochat.ai/papers/10.1093/ajcn/nqaa347
- The paper
- Stonehouse, W., Sergi, D., Benassi-Evans, B., James-Martin, G., Johnson, N., Thompson, C. H., & Abeywardena, M. (2021). Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/nqaa347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.